Commentary: risks and benefits, testing and screening, cancer, genes and dollars.
Author argues that the current, restrictive policy for genetic screening for cancer risk is appropriate but that diagnostic testing decisions should not be so narrowly regulated.
Kodish
E
E
Case Western Reserve University School of Medicine, Cleveland, USA.
D026683:Advisory Committees; D003362:Cost-Benefit Analysis; D003657:Decision Making; D005817:Genetic Counseling; D020022:Genetic Predisposition to Disease; D030661:Genetic Privacy; D033142:Genetic Services; D005820:Genetic Testing / Q000191:economics; D006801:Humans; D009369:Neoplasms / Q000191:economics / Q000517:prevention & control*; D018570:Risk Assessment; D014481:United States